Michael Fritz

Michael Fritz is a Senior Associate at Roo Partners based in New York City, where he focuses on sourcing and managing growth equity investments. Promoted to his current role in 2024, he recently participated in the firm's $250 million Fund III close in the first quarter of 2025. At the firm, which manages over $1 billion in assets, he has contributed to investments in portfolio companies such as Everstage, Nymbl Science, and PatientCall. Prior to joining Roo Partners, he worked as an Analyst at the venture capital firm LLR Partners and earned a Bachelor of Science in Finance from the University of Maryland's Robert H. Smith School of Business. His current investment focus centers on providing strategic capital and operational guidance to growth-stage businesses operating across the technology, software, fintech, and healthcare SaaS sectors.